Search results
Author(s):
Pugazhendhi Vijayaraman
Added:
1 year ago
AHA 2023 — In this short interview, we are joined by Dr Pugazhendhi Vijayaraman (Geisinger Heart Institute, US) to discuss the findings of the I-CLAS study, an international collaborative investigation into left bundle branch area pacing.This retrospective observational study compared the arrhythmic risk in biventricular pacing as compared to left bundle branch area pacing. 1778 Patients were…
View more
Atrioventricular (AV) Valves Summit 2024
Video Series
Conduction System Pacing: A Fresh Look
Author(s):
Óscar Cano
,
Marek Jastrzębski
,
Pugazhendhi Vijayaraman
Start date:
Nov 13, 2024
Broadcast
Author(s):
Larry Chinitz
Added:
11 months ago
HRS 24 - Dr Larry Chinitz (NYU School of Medicine, US) joins us to discuss the findings of the prospective, multicenter BIO-CONDUCT study, which investigated the safety and efficacy of the BIOTRONIK Solia S pacing lead implanted in the left bundle branch area (LBB) (NCT05251363, Biotronik Inc.). 186 patients with atrioventricular block, bradycardia, left bundle-branch block or cardiomyopathies…
View more
Author(s):
Christophe Leclercq
Added:
1 month ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire…
View more
Author(s):
,
Added:
1 year ago
In this series of short interviews and discussions filmed at AV Valves Summit 2023, the faculty delve into sharing invaluable insights and expert opinion on transcathetermitral and tricuspid intervention.
They examine a range of topics which include the development of TEER, the importance of quality of life, repair vs replacement and how to best shape the future of MR and TR treatment.
The AV…
View more
Author(s):
Mads Brix Kronborg
Added:
1 year ago
ESC 2023 — Dr Mads Brix Kronborg (Aarhus University Hospital, DE) joins us to discuss the findings from the DANPACE II Trial (NCT00236158).
DANPACE II (The DANPACE Investigator Group) trial aimed to compare patients who were randomised in a 1:1 ratio to either a base rate of 60 beats per minute and rate-adaptive DDD (DDDR-60 Group) or a base rate of 40bpm and non-rate adaptive DDD (DDD-40…
View more
Author(s):
Apostolos Ilias Vouliotis
,
Paul Roberts
,
Polychronis Dilaveris
,
et al
Added:
1 year ago
Comment on Leadless Pacemakers
Author(s):
Zaki Akhtar
,
Manav Sohal
,
Mark M Gallagher
Added:
1 year ago
Article